Latest News for: nls

Edit

Notice of Effectiveness (Form EFFECT) (NLS Pharmaceutics Ltd)

Public Technologies 23 Sep 2026
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. Notice of Effectiveness ... NLS Pharmaceutics Ltd.
Edit

NewcelX Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2026 (Form 6-K) (NLS Pharmaceutics Ltd)

Public Technologies 19 Sep 2026
This discussion and other parts of the interim report contain forward-looking statements based upon current expectations that involve risks and uncertainties ... CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS ... Disclaimer. NLS Pharmaceutics Ltd.
Edit

NEWCELX LTD. AND ITS SUBSIDIARIES INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Form 6-K) (NLS Pharmaceutics Ltd)

Public Technologies 19 Sep 2026
Other expenses (expenses for merger with NLS) - (101 ) ... (formerly known as NLS Pharmaceutics Ltd.) (the "Company") was established on June 10, 2015, as a Swiss limited company ... NLS Pharmaceutics Ltd.
Edit

Post-Effective Amendment to Registration Statement (Form POS AM) (NLS Pharmaceutics Ltd)

Public Technologies 19 Sep 2026
10.26 Agreement and Plan of Merger, dated as of November 4, 2024, by and among NLS Pharmaceutics Ltd., NLS Pharmaceutics (Israel) Ltd ... and among NLS Pharmaceutics Ltd., NLS Pharmaceutics (Israel) Ltd.
Edit

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy (NLS Pharmaceutics Ltd)

Public Technologies 08 Jul 2026
) The Longevity Protein Race Reaches Manufacturing. One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy. PR Newswire. Issued on behalf of Avaí Bio, Inc ... (OTCQB. AVAI), Sana Biotechnology, Inc. (NASDAQ ... NLS Pharmaceutics Ltd.
Edit

NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board (Form 6-K) (NLS Pharmaceutics Ltd)

Public Technologies 08 Jul 2026
). NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board. The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND ... Dr ... (Nasdaq ... Dr ... "Dr ... Dr ... Dr ... 2 ... NLS Pharmaceutics Ltd.
Edit

GIPE Selects TheNLS.com as Its Strategic Technology Partner to Deliver Spain's Most Advanced Digital Real ...

Pressat 07 Jul 2026
The partnership creates GIPE MLS – Powered by The NLS, combining GIPE's more than four ... The NLS's next-generation technology platform, designed specifically for professional real estate ... This agreement with The NLS gives our members access to a.
  • 1

Article Search

tools
×
×
×
×